Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
2 Bekeken
administrator
08/04/23
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Laat meer zien
Facebook Reacties
Geen reacties gevonden